Cargando…
Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
Cutaneous T‐cell lymphomas (CTCLs) are telomerase‐positive tumors expressing hTERT, although neither gene rearrangement/amplification nor promoter hotspot mutations could explain the hTERT re‐expression. As the hTERT promoter is rich in CpG, we investigated the contribution of epigenetic mechanisms...
Autores principales: | Chebly, Alain, Ropio, Joana, Peloponese, Jean‐Marie, Poglio, Sandrine, Prochazkova‐Carlotti, Martina, Cherrier, Floriane, Ferrer, Jacky, Idrissi, Yamina, Segal‐Bendirdjian, Evelyne, Chouery, Eliane, Farra, Chantal, Pham‐Ledard, Anne, Beylot‐Barry, Marie, Merlio, Jean‐Philippe, Tomb, Roland, Chevret, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067155/ https://www.ncbi.nlm.nih.gov/pubmed/33715271 http://dx.doi.org/10.1002/1878-0261.12946 |
Ejemplares similares
-
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells
por: Chebly, Alain, et al.
Publicado: (2021) -
Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas
por: Chebly, Alain, et al.
Publicado: (2022) -
Spotlight on hTERT Complex Regulation in Cutaneous T-Cell Lymphomas
por: Ropio, Joana, et al.
Publicado: (2023) -
hMZF-2, the Elusive Transcription Factor
por: Chebly, Alain, et al.
Publicado: (2020) -
Reliable blood cancer cells' telomere length evaluation by qPCR
por: Ropio, Joana, et al.
Publicado: (2020)